| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $144,479,333 ) (Continued on the next page) |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL175060 | Genetic architecture of tissue factor expression | 000 | 3 | NIH | 8/24/2026 | $642,991 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K01HL161034 | Admixture Mapping of Coronary Heart Disease and Associated Metabolomic Markers | 000 | 4 | NIH | 3/31/2026 | $158,454 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | P01AI179405 | Lupus nephritis: novel insights in the pathogenesis and treatment | 001 | 3 | NIH | 3/24/2026 | $0 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | P01AI179405 | Lupus nephritis: novel insights in the pathogenesis and treatment | 000 | 3 | NIH | 1/22/2026 | $2,211,043 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL171042 | Regulation of coagulation and thrombosis by C1 inhibitor | 002 | 3 | NIH | 7/17/2026 | $690,184 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NR021686 | Leveraging SNAP Policies to Improve Cardiovascular Health in the United States | 000 | 3 | NIH | 5/19/2026 | $713,365 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | U54AG062322 | Center for Stress and Neural Regulation of Reproductive Aging Health Outcomes | 003 | 7 | NIH | 9/16/2026 | $1,472,465 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R00AG076739 | Cis proline directed proteotoxicity in the early development and therapy of traumatic brain injury and vascular dementia | 000 | 5 | NIH | 8/13/2026 | $248,895 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA258776 | Pan-Cancer characterization of 3’UTR somatic mutations controlling tumor immune evasion | 001 | 5 | NIH | 4/16/2026 | $56,402 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA258776 | Pan-Cancer characterization of 3’UTR somatic mutations controlling tumor immune evasion | 000 | 5 | NIH | 1/16/2026 | $507,623 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | DP1DK139958 | High-dimensional chemical targeting of multiple neuron types to regulate energy balance | 000 | 3 | NIH | 8/27/2026 | $800,000 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL188729 | Molecular Determinants of Dynamic Blood Pressure Regulation and Cardiovascular Disease | 000 | 1 | NIH | 9/4/2026 | $853,092 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21CA317274 | Harnessing Cuproptosis Against Chemoresistant Ovarian Cancer | 000 | 1 | NIH | 9/3/2026 | $444,569 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21AR088602 | An Oleoyl Serine Derivative as an Innovative Therapeutic Approach for Osteoporosis | 000 | 1 | NIH | 9/17/2026 | $430,816 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK148663 | Leptin transport in the choroid plexus and tanycytes | 000 | 1 | NIH | 9/11/2026 | $876,947 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K99AA032847 | The multi-organ role of NETs in alcohol-induced ACLF | 000 | 1 | NIH | 8/20/2026 | $177,736 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21AI196617 | Impact of Diet on Symptomatic Hereditary Alpha-Tryptasemia | 000 | 1 | NIH | 7/15/2026 | $306,533 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K22CA288779 | Early detection and interception of cancer using the mutational signature methodology | 000 | 1 | NIH | 8/13/2026 | $191,484 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | RF1AG079799 | Molecular mechanisms of aging and accelerated aging in the human brain | 000 | 4 | NIH | 8/20/2026 | $1,673,435 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK142743 | Selective brain-to-gut communication via transcriptionally-defined vagus-to-enteric neuron circuits | 000 | 1 | NIH | 3/18/2026 | $834,911 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23AG090744 | Development and Pilot Testing of an Electronic Health Record-based Serious Illness Communication Intervention for Older Adults in the Emergency Department | 001 | 2 | NIH | 9/8/2026 | $191,484 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK146795 | Adiponectin Signaling in Bladder Function | 000 | 1 | NIH | 4/24/2026 | $739,141 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK145097 | APOL1 Nephropathy: Linking Genetics and Mechanisms | 000 | 7 | NIH | 7/1/2026 | $659,358 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21NS146763 | Lateral hypothalamic neurotensin neurons in the pathophysiology of narcolepsy | 000 | 1 | NIH | 9/1/2026 | $475,475 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL185389 | Cardiac MRI Phenotyping of Coronary Microvascular Dysfunction | 000 | 1 | NIH | 6/12/2026 | $848,141 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA314254 | One-ended Break Repair in Mammalian Cells | 000 | 1 | NIH | 5/11/2026 | $524,110 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21AI199146 | Development of next generation spectinomycin analogs that evade modifying enzyme-based resistance and show enhanced potency against multidrug-resistant pathogens. | 001 | 1 | NIH | 7/29/2026 | $0 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21AI199146 | Development of next generation spectinomycin analogs that evade modifying enzyme-based resistance and show enhanced potency against multidrug-resistant pathogens. | 000 | 1 | NIH | 6/30/2026 | $493,865 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K01AA032055 | Role of Hepatokines in Alcohol-associated Liver Disease | 000 | 2 | NIH | 8/12/2026 | $177,736 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23HL183787 | Strategies to Improve Inhaler Access, Adherence, and Clinical Outcomes in US Adults with Asthma and COPD | 000 | 1 | NIH | 9/10/2026 | $168,926 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AA032418 | Innate immune dysregulation in alcohol-associated liver disease | 000 | 2 | NIH | 6/3/2026 | $670,649 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K01AG100532 | Caloric Restriction-Regulated Non-Coding RNAs as Modulators of Adipose Tissue Aging and Senescence | 000 | 1 | NIH | 9/7/2026 | $106,605 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21AG102442 | Spatially Validated Human Lymphoid Follicles-on-Chip for Modeling Inflammaging and Age-Related Immune Dysfunction | 000 | 1 | NIH | 8/20/2026 | $518,555 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL180838 | ADAMTS13 in Human Health and Disease | 000 | 1 | NIH | 6/16/2026 | $1,626,320 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | F32HL186556 | Investigating Inflammatory Pathways in Pulmonary Vascular Disease | 000 | 1 | NIH | 6/25/2026 | $92,476 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | F32GM167172 | Single-Molecule Dissection of Hypomethylation-Driven Genome Instability | 001 | 1 | NIH | 7/23/2026 | $0 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | F32GM167172 | Single-Molecule Dissection of Hypomethylation-Driven Genome Instability | 000 | 1 | NIH | 7/23/2026 | $79,300 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AI202713 | Development of a Novel Trivalent Adjuvanted TB Vaccine | 000 | 1 | NIH | 7/31/2026 | $648,375 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | RF1AG096648 | Adverse Effect of Excessive Amyloid Peptides to Brain Lymphatic Function | 000 | 1 | NIH | 7/31/2026 | $3,481,644 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AI202713 | Development of a Novel Trivalent Adjuvanted TB Vaccine | 000 | 1 | NIH | 7/31/2026 | $648,375 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS149672 | Meningeal sensory neuroimmune interactions underlying migraine headache | 000 | 1 | NIH | 7/24/2026 | $749,073 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | RF1MH144469 | ?DIGITS: DIGital health Interoperability Technology Standards | 000 | 1 | NIH | 8/3/2026 | $2,961,081 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AA032953 | Myeloid-derived suppressor cells in alcohol-associated steatohepatitis | 000 | 1 | NIH | 8/26/2026 | $682,736 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL178578 | Serotonergic circuit mechanisms to enhance upper airway tone and respiration in the setting of opioids and sleep-disordered breathing. | 000 | 1 | NIH | 8/5/2026 | $1,738,060 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HD119808 | Mechanisms and Therapeutic Approaches for Lymphatic Pathology Caused by Dysregulated NFATc1 | 000 | 6 | NIH | 8/27/2026 | $724,852 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K08HL181191 | Vascular Piezo1 in Thrombosis | 000 | 1 | NIH | 8/12/2026 | $164,484 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL183196 | Elastin-Like Polypeptide Nanoparticles for Precision Gene Therapy of Cystic Fibrosis | 000 | 1 | NIH | 8/26/2026 | $852,908 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21AG103494 | Suburothelial Myofibroblasts Function in Young and Aging Bladder | 000 | 1 | NIH | 7/10/2026 | $475,475 |
| | 2026 | 2026 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K99HD120622 | Investigating relationships between sexual behavior rhythms, core body temperature, and sleep in female mice: implications for (in)fertility | 000 | 1 | NIH | 8/27/2026 | $129,377 |
|
